Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Goldstein, Edward ^a   Cowling, Benjamin J ^b   O'Hagan, Justin J ^a   Danon, Leon ^a,c   Fang, Vicky J ^b   Hagy, Angela ^d   Miller, Joel C ^a,f   Reshef, David ^e   Robins, James ^a   Biedrzycki, Paul ^d   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d Milwaukee Department of Public Works   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ANTIVIRUS AGENT;

ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG USE; HOUSEHOLD; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA A (H1N1); PANDEMIC INFLUENZA; RISK REDUCTION; SECONDARY INFECTION; UNITED STATES; ADULT; CHILD; FAMILY HEALTH; FAMILY SIZE; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; METHODOLOGY; PRESCHOOL CHILD; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, INFECTIOUS; FAMILY CHARACTERISTICS; FAMILY HEALTH; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; OSELTAMIVIR; WISCONSIN;

EID: 77954676992     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-211     Document Type: Article

References (20)

1. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, Griffiths M, Waalberg E, Ward P, . on behalf of the IMPACT Study Group Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003, 51(1):123-9. 10.1093/jac/dkg007, 12493796, on behalf of the IMPACT Study Group.
2. Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ Duffy S, Westwood M, Palmer S, Stewart L. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis 2009, 9(9):537-545. 10.1016/S1473-3099(09)70199-9, 19665930.
3. McClellan K, Perry CM. Oseltamivir: a review of its use in influenza. Drugs 2001, 61(2):263-83. 10.2165/00003495-200161020-00011, 11270942.
4. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser KA, Samuel MC, Rosenberg J, Talarico J, Hatch D, . The California Pandemic (H1N1) Working Group Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302(17):1896-1902. 10.1001/jama.2009.1583, 19887665, The California Pandemic (H1N1) Working Group.
5. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, David Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L, . The 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med 2009, 361(20):1991-3. 10.1056/NEJMoa0906695, 19907047, The 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team.
6. Goldstein E, Miller JC, O'Hagan JJ, Lipsitch M. Predispensing of Antivirals to High-Risk Individuals in an Influenza Pandemic. Influenza Other Respi Viruses 2010, 4(2):101-12. 10.1111/j.1750-2659.2009.00128.x, 20167050.
7. Halloran EM, Hayden FG, Yang Y, Longini IM, Monto AS. Antiviral Effects on Influenza Viral Transmission and Pathogenicity: Observations from Household-based Trials. Amer J Epidem 2007, 165(2):212-221.
8. Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DKM, Cheng CK, Uyeki TM, Houck PM, Malik Peiris JS, Leung GM. Effects of oseltamivir treatment on duration of clinical illness and viral shedding, and household transmission of influenza virus. Clinical Infectious Diseases 2010, 50(5):715-6. 10.1086/650458, 20121572.
9. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73(1):13-22.
10. Field CA, Welsh AH. Bootstrapping clustered data. Journal of the Royal Statistical Society Series B 2007, 69(3):369-390.
11. Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004, 15(5):615-625. 10.1097/01.ede.0000135174.63482.43, 15308962.
12. Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain New influenza A(H1N1) virus infections in Spain, April-May 2009. Euro Surveill 2009, 14(14). Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain.
13. Cowling BJ, Fang VJ, Riley S, Malik Peiris JS, Leung GM. Estimation of the Serial Interval of Influenza. Epidemiology 2009, 20(3):344-347. 10.1097/EDE.0b013e31819d1092, 19279492.
14. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, Kent CK, Finelli L, Ferguson NM. Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States. NEJM 2009, 361(27):2619-2627. 10.1056/NEJMoa0905498, 20042753.
15. White L, Wallinga J, Finelli L, Reed C, Riley S, et al. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Inf Resp Vir 2009, 3(6):267-27.
16. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Azra C, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Palacios Zavala E, Espejo Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C, . The WHO Rapid Pandemic Assessment Collaboration Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings. Science 2009, 324(5934):1557-1561. 10.1126/science.1176062, 19433588, The WHO Rapid Pandemic Assessment Collaboration.
17. Kenah E, Lipsitch M, Robins JM. Generation interval contraction and epidemic data analysis. Mathematical Biosciences 2008, 213(1):71-79. 10.1016/j.mbs.2008.02.007, 2365921, 18394654.
18. Morgan OW, Parks S, Shim T, Blevins PA, Lucas PM, Sanchez R, Walea N, Loustalot F, Duffy MR, Shim MJ, Guerra S, Guerra F, Mills G, Verani J, Alsip B, Lindstrom S, Shu B, Emery S, Cohen AL, Menon M, Fry AM, Dawood F, Fonseca VP, Olsen SJ. Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009. Emerg Infect Dis 2009, 16(4):631-7.
19. Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithaworn S, Burke DS. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005, 437(7056):209-14. 10.1038/nature04017, 16079797.
20. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, Low DE, . Toronto Invasive Bacterial Diseases Network Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007, 45(12):1568-75. 10.1086/523584, 18190317, Toronto Invasive Bacterial Diseases Network.